https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34513 Wed 27 Apr 2022 14:49:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29875 Wed 27 Apr 2022 14:49:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30030 Wed 27 Apr 2022 14:49:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16106 Wed 11 Apr 2018 16:02:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19406 Wed 11 Apr 2018 15:19:32 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19643 Wed 11 Apr 2018 10:26:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30899 P = 0.039). In a sensitivity analysis including only trainees attending the workshop, 80.0% pre-intervention and 97.1% postintervention tapered opioids (P = 0.070). Anticipated initiation of any opioids for a chronic osteoarthritic knee pain clinical vignette reduced from 35 (74.5%) to 24 (51.1%; P = 0.012) in the primary analysis and from 80.0% to 41.7% in the sensitivity analysis (P = 0.001). Conclusions: Necessary improvements in pain management and opioid harm avoidance are predicated on primary care education being of demonstrable efficacy. This brief educational intervention improved hypothetical management approaches two months subsequently. Further research measuring objective changes in physician behavior, especially opioid prescribing, is indicated.]]> Wed 04 Sep 2019 09:55:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46737 Tue 29 Nov 2022 14:29:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32043 Tue 24 Apr 2018 13:52:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43082 Tue 13 Sep 2022 12:19:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29246 Tue 05 Jul 2022 14:14:07 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29230 Tue 05 Jul 2022 14:13:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33267 Tue 03 Sep 2019 18:26:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48448 34 years, the patient being new to the registrar, one particular regional training provider (RTP), in-consultation information or assistance being sought and learning goals being generated. Outer regional-, remote-or very remote-based registrars made significantly fewer ED referrals than more urban registrars. Of the problems referred to the ED, 45.5% involved the seeking of in-consultation information or assistance, predominantly from supervisors. Conclusions: Registrars' ED referral rates are nearly twice those of established GPs. The findings of the present study suggest acute illnesses or injuries present registrars with clinical challenges and real learning opportunities, and highlight the importance of continuity of care, even for acute presentations. What is known about the topic?: A GP's decision concerning continued community-versus hospital-based management of acute presentations demands careful consideration of a suite of factors, including implications for patient care and resource expenditure. General practice vocational training is a critical period for the development of GP registrars' long-term patterns of practice. Although limited international evidence suggests GP registrars and early career GPs refer patients to the ED at a higher rate than their more experienced peers, these studies involved small subject numbers and did not investigate associations of registrars making an ED referral. Relevant Australian studies focusing on GP registrars' ED referral patterns are lacking. What does this paper add?: The present ongoing cohort study is the first to establish the patterns of ED referrals made by Australian GP registrars, encompassing five general practice RTPs across five states, with participating registrars practising in urban, rural, remote and very remote practices. Several significant associations were found with GP registrars making ED referrals, including patient age, continuity of care, the registrar's RTP, assistance sought by the registrar and rurality of the registrar's practice. What are the implications for practitioners?: The higher likelihood of GP registrars seeing acute presentations than their more established practice colleagues, coupled with a demonstrated association of registrars seeking in-consultation assistance for such presentations, highlights the importance of GP supervisor accessibi]]> Thu 16 Mar 2023 17:33:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43260 Thu 15 Sep 2022 11:06:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43251 Thu 15 Sep 2022 10:24:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33729 Thu 13 Dec 2018 15:22:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46717 Thu 01 Dec 2022 10:20:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13913 C) and rs5275 (T > C) polymorphisms was performed by real-time polymerase chain reaction using allele-specific probes. Results: Ingestion of any NSAID in the week prior to interview was associated with an elevated risk for ACS: adjusted odds ratio 1.8 (1.2, 2.5). The rs 20417 and rs 5275 polymorphisms were not singly associated with risk for ACS: adjusted odds ratios 1.1 (0.80, 1.5) and 1.2 (0.88, 1.5), respectively. Individually, the polymorphisms did not modify the risk of ACS with the drugs. When analyses were conducted by haplotype, the adjusted odds ratio with celecoxib or rofecoxib in individuals who had one or two copies of the ‘low risk’ haplotype (no GT) was 1.2 (0.29, 5.0), compared with 2.1 (1.1, 4.0) with the ‘high risk’ haplotype (one or two copies of GT). Conclusions: We found little evidence of a gene/drug interaction. We found a statistically non-significant trend toward a lower risk of coronary events with NSAIDs in the presence of the ‘low risk’ haplotype. Even if confirmed, the clinical utility of the finding would be limited as this haplotype is carried by a minority of the population.]]> Sat 24 Mar 2018 08:25:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20731 Sat 24 Mar 2018 08:00:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26889 Sat 24 Mar 2018 07:41:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29358 Sat 24 Mar 2018 07:34:17 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27027 Sat 24 Mar 2018 07:30:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28249 Sat 24 Mar 2018 07:28:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23018 Sat 24 Mar 2018 07:16:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22881 Sat 24 Mar 2018 07:12:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27838 Mon 13 Jul 2020 13:41:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27290 Fri 25 Sep 2020 12:37:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46526 Fri 25 Nov 2022 09:41:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33265 Fri 21 Sep 2018 14:23:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33268 Fri 21 Sep 2018 14:23:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33270 Fri 21 Sep 2018 14:23:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33266 Fri 21 Sep 2018 14:23:18 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32972 Fri 17 Aug 2018 11:45:43 AEST ]]>